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Crystal Structure of sTALL-1 Reveals
a Virus-like Assembly of TNF Family Ligands
trimer through highly conserved hydrophobic surfaces.
The trimer also exists in solution. Structures of TNF,
CD40L, and TRAIL were subsequently determined (Eck
Yingfang Liu,1 Liangguo Xu,1,2 Natasha Opalka,5
John Kappler,1,3,4 Hong-Bing Shu,1,2
and Gongyi Zhang1,3,6
et al., 1992; Karpusas et al., 1995; Cha et al., 1999). These1National Jewish Medical and Research Center
structures are similar to the TNF structure, although theIntegrated Department of Immunology
sequence homology is low (20%–25%) among the TNF2 Cancer Center
family members. These studies led to proposals that all3 Department of Pharmacology
TNF family members have similar structures and func-Biomolecular Structure Program
tion as trimers (Locksley et al., 2001; Fesik, 2000). Due4 Howard Hughes Medical Institute
to the scarcity of available structures (4 of 18) and lowSchool of Medicine
sequence homology among the TNF family members,Colorado University Health Science Center
the generality of this conclusion is unclear.1400 Jackson Street
The structure of the complex of TNF and cysteine-Denver, Colorado 80206
rich domains (CRDs) from its cognate receptor, TNFR1,5 The Rockefeller University
has also been determined (Banner et al., 1993). The1230 York Avenue
structure showed that the three elongated receptor do-New York, New York 10021
mains bind to one TNF trimer at the interfaces formed
between the TNF monomers. Two CRDs (CRD2 and CRD3)
make contacts with two distinct regions of TNF. TheSummary
recently determined complex structure of TRAIL and DR5
disclosed a similar interaction mode, as observed in theTALL-1/BAFF/BLyS was recently identified as a mem-
TNF and TNFR1 cocrystal structure, although CRD3 ofber of the tumor necrosis factor (TNF) ligand family.
DR5 assumes a different orientation compared to theThe crystal structure of the functional soluble TALL-1
CRD3 in the TNF and TNFR1 structure (Mongkolsapaya(sTALL-1) has been determined at 3.0 A˚. sTALL-1
et al., 1999; Hymowitz et al., 1999). It was proposed thatforms a virus-like assembly with 200 A˚ diameter in
the TNF trimeric ligands trigger the trimerization of theirthe crystals, containing 60 sTALL-1 monomers. The
cognate receptors, which causes the cytoplasmic re-cluster formation is mediated by a “flap” region of the
gions of the receptor to form a cluster that can recruitsTALL-1 monomer. The virus-like assembly was also
adaptor proteins, leading to the activation of down-detected in solution using gel filtration and electron
stream signal transduction pathways (Fesik, 2000; Ban-microscopy. Deletion of the flap region disrupted the
ner et al., 1993; Mongkolsapaya et al., 1999; Hymowitz etformation of the virus-like assembly. The mutant
al., 1999). This theory is now challenged by new findingssTALL-1 still bound its receptor but could not activate
showing that TNF receptor and Fas exist in an oligomericNF-B and did not stimulate B lymphocyte proliferation.
state through the preligand binding assembly domainFinally, we found the virus-like cluster of sTALL-1 exists
(PLAD) before the binding of ligands (Chan et al., 2000;in physiological condition. We propose that this virus-
Siegel et al., 2000).like assembly of sTALL-1 is the functional unit for
TALL-1, also known as BAFF, THANK, BlyS, andTALL-1 in vivo.
zTNF4, and its receptors BCMA, BAFF-R, and TACI are
four recently identified TNF/TNFR (TNF receptor) familyIntroduction
members (Shu et al., 1999; Schneider et al., 1999; Moore
et al., 1999; Mukhopadhyay et al., 1999; Shu and John-
TNF (tumor necrosis factor) family ligands and their cor-
son, 2000; Gross et al., 2000; Thompson et al., 2000,
responding receptors (TNFR) play pivotal roles in mam- 2001; Marsters et al., 2000; Xia et al., 2000; Yan et al.,
malian cell host defense processes, inflammation, apo- 2000, 2001). Overexpression of sTALL-1 in mice leads
ptosis, autoimmunity, and organogenesis. There are at to increased numbers of mature B lymphocytes, speno-
least 18 TNF ligands and 27 receptors identified so far. megaly, anti-DNA antibodies, proteinuria, and glomeru-
Some ligands have multiple receptors, and some recep- lonephritis. These phenotypes mimic those of systemic
tors also bind multiple ligands. The interactions between lupus erythemia (Shu and Johnson, 2000; Gross et al.,
ligands and receptors are usually very specific and have 2000; Thompson et al., 2000; Marsters et al., 2000; Xia
high apparent affinity (0.1–1.0 nM) (Locksley et al., 2001; et al., 2000; Yan et al., 2000; Mackay et al., 1999; Khare
Fesik, 2000). et al., 2000). The experiments of BAFF knockout showed
The first TNF ligand trimer structure (TNF) was deter- that BAFF was absolutely required for normal B cell
mined more than a decade ago (Jones et al., 1989; Eck development (Schiemann et al., 2001; Gross et al., 2001).
and Sprang, 1989). It consists entirely of  strands and The phenotype is similar to that caused by BAFF-R defi-
loops. The structure has a standard “jellyroll” topology ciency (Thompson et al., 2001, Yan et al., 2001). On the
and is remarkably similar to capsid proteins of small other hand, the knockouts of BCMA and TACI did not
RNA viruses such as satellite tobacco necrosis virus lead to any severe B cell phenotypes (Xu and Lam, 2001;
(Jones and Liljas, 1984). Three monomers of TNF form a von Bulow et al., 2001). Interestingly, APRIL (also called
TALL-2), the closest family member of TALL-1, does not
bind to BAFF-R (Schiemann et al., 2001), although it6 Correspondence: zhangg@njc.org
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Table 1. Experimental Data on Crystal Structure Determination and Refinement
Resolution Number of Total Completeness Phasing Number
Data Set (A˚) Rmerge (%) Unique Reflections Observations (%) Power of Sites
Native 3.0 11.7 66,001 334,821 95.7
HgCl2 3.0 14.6 111,792 317,553 85.2 1.39 10
Mersaly1 3.2 11.4 101,595 247,096 94.5 0.67 10
Mean Figure of Merit  0.37 (for 54,518 phased reflections)
Refinement
Resolution (A˚) 20–5.95 4.75 4.15 3.78 3.51 3.30 3.14 3.0
Number of reflections 7,850 7,545 7,472 7,158 6,732 6,328 4,927 3,740 51,752
R factor 23.12 21.06 18.73 22.84 25.08 27.78 31.34 33.67 23.61
Free R factor 25.48 21.37 20.45 24.71 26.92 28.07 33.48 35.03 25.22
Rmerge  |Ij  I|/Ij with Bijvoet pairs treated as equivalent for native and as different for derivatives.
Total observations is the number of full and partial observations measured with nonnegative intensity to the indicated resolution.
Completeness is the percentage of possible unique reflections measured with I/(I) 	 0 to the indicated resolution.
Phasing power  FH/Erms.
Number of reflections is the number of reflections used in refinement for each resolution bin.
R factor  |Fo  Fc|/Fo for all amplitudes with F/(F) 	 2 measured in the indicated resolution bin; the free R factor is calculated with 5%
of the data in each bin.
binds to BCMA and TACI with an affinity similar to regions among the TNF family ligands. Two additional
unique features are termed “elbow” and “flap” regionssTALL-1 (Yu et al., 2000).
(Figure 1A). The elbow region contains a short  hairpinIn contrast to the other receptor family members that
labeled A

 and A


. There is a similar region in TRAIL,have at least three to four CRDs in their extracellular
which is not well defined from the available structuresdomains, BCMA and BAFF-R have only one CRD and
of TRAIL, contrasting with the well-ordered  hairpin ofTACI has two CRDs (Shu and Johnson, 2000; Gross et
sTALL-1 (Cha et al., 1999; Mongkolsapaya et al., 1999;al., 2000; Thompson et al., 2000, 2001; Marsters et al.,
Hymowitz et al., 1999). The flap region is unique to2000). Nevertheless, the overall binding affinities of
sTALL-1, based on results of sequence alignments andsTALL-1 with BCMA and TACI (0.1–1.0 nM) are similar
structural comparisons (Figures 1B and 1D). There is alsoto those of other family members (Yu et al., 2000). To
a disulfide bridge between residue Cys232 on strand Ebegin to understand the structure and function relation-
and residue Cys245 on strand F, which is unique forship of TALL-1 and its receptors, we determined the
TALL-1, TALL-2, Tweak, and EDA (Bodmer et al., 2000).crystal structure of sTALL-1.
The interfaces that form the trimer of sTALL-1 mostly
consist of layered aromatic residues including Phe194,
Results and Discussion
Tyr196, and Tyr246 from three monomers, which are
conserved for all TNF ligand family members. Interest-
Overall Structure ingly, one triple phenylalanine layer in TNFa, TNFb,
The structure of the soluble portion of TALL-1 was deter- CD40L, and TRAIL is replaced by triple Leu282s in
mined by the multiple isomorphous replacement method sTALL-1 trimer. There are two additional interaction lay-
using two mercury derivatives (Table 1). The electron ers of triple residues in sTALL-1 trimer. One consists of
density map was improved by solvent flattening. The residues Gln144 from reach monomers, forming an H
structure has been refined to an R factor of 23.6% (Rfree bond net. Another layer is formed by three Leu285 resi-
of 25.2%) against data extending to 3.0 A˚ resolution in dues from C terminus of three monomers. The hy-
space group P6322, with ten sTALL-1 monomers in the drophobic interactions appear to be the main forces
asymmetric unit (unit cell of 234  234  217 A˚). The driving trimer formation.
current model of the sTALL-1 monomer contains residues The unique flap region of sTALL-1 mediates trimer-
142–285, with all side chains well defined (Figure 1A). trimer interactions that lead to a remarkable virus-like
The structure of sTALL-1 consists of two layered anti- assembly of the sTALL-1 trimers. There are ten sTALL-1
parallel  strands that form a typical jellyroll-like  sand- monomers in the asymmetric unit with a space group
wich, as with other members of the TNF ligand family of P6322 (Figure 2A). The ten monomers interact to form
(Jones et al., 1989; Eck and Sprang, 1989; Eck et al., virus-like clusters containing 60 sTALL-1 monomers (20
1992; Karpusas et al., 1995; Cha et al., 1999). Compared trimers; Figures 2B and 2C). Within the unit cell, there
to known structures of other family members, the overall are two virus-like clusters. This structure resembles the
structure of sTALL-1 is shorter along the three-fold axis T 1 virus structures such as satellite tobacco necrosis
that generates the trimers (Figure 1B). This was even virus (STNV, Protein Data Bank accession number 2STV;
more obvious when the trimers of sTALL-1 and TNF Jones and Liljas, 1984). The overall rmsd of main chain
were superimposed, which generated an overall rmsd is 2.1 A˚ between sTALL-1 and STNV. In STNV structure,
of 1.9 A˚ (Figure 1C). The effect is caused by the shorten- five monomers form a pentamer, a virus envelope is
ing of two  strand pairs, CD and EF (Figure 1A). This built up by 12 pentamers, and the interactions among
is consistent with the fact that the connecting regions pentamers are mediated by two short helices. Interest-
ingly, when the structure of TNF was reported, thethat link strands CD, EF, and GH are the most divergent
A Virus-like Structure of TNF Ligand
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Figure 1. The Similarity and Difference between sTALL-1 and TNF
(A) Ribbon diagram of the three-dimensional structure of sTALL-1 (residues 142–285; Carson, 1987). Elbow and flap regions are unique for
sTALL-1 and termed for their shapes. Starting from the N terminus, A (146–151) → A


 (158–160) → A

 (163–165) → A
 (168–174) → B
 (178–181)
→ B (184–187) → C (191–201) → D (208–215) → E (226–235) → F (245–253) → G (258–242) → H (270–283).
(B) Stereo view of superimposing sTALL-1 onto TNF (PDB ID, 1TNF). sTALL-1 is green; TNF is yellow.
(C) Ribbon representation of sTALL-1 trimer, looking down from the three-fold axis that generates the trimer.
(D) Stereo view of superimposing of sTALL-1 trimer and TNF trimer, viewing from the orientation vertical to the three-fold axis. sTALL1-1 is
green; TNF is gray.
authors noticed the structural similarity between TNF interfaces that bring two trimers together, two of which
are involved in the interactions of two momoners, layerand the capsid protein of STNV (Jones et al., 1989).
Moreover, they speculated that these two proteins could 1 and layer 2, respectively (Figure 3B). Layer 1 consists
of residues Tyr192, Lys252, Glu254, and His218 fromhave evolved from a common ancestor and that TNF
may form a virus-like structure under certain circum- one monomer and residues Tyr192
, Lys252
, Glu254
,
and His218
 from another monomer. The side chains ofstances (Jones et al., 1989). The structure of sTALL-1 is
a piece of strong evidence supporting that speculation. residues Lys252 and Glu254 form ionic bonds with those
of residues Glu254
 and Lys252
. These interactions are
further strengthened by the hydrogen bond net formedTrimer-Trimer Interactions
The trimer-trimer interactions are extensive. They include by side chains of all residues from this layer (Figures
3C and 3D). Interestingly, except residues His218 andnot only hydrogen bond networks and salt bridges but
also hydrophobic contacts. Residues involved in trimer- His218
 from the flap regions, all others are from 
strands C and F. These interactions could exist in othertrimer interactions are from not only the monomer that
contributes the flap region but also the neighboring TNF ligand members that do not contain a distinguish-
able flap region. Further investigation of the biologicalmonomer as well (Figures 3A and 3B). Due to the resolu-
tion limitation, detailed hydrogen bond networks will not consequence of the interaction for other members will
be of great interest and importance.be discussed here. There are three major interaction
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Layer 2 consists of residues Lys216, Glu223, Leu224,
Val227, and Leu229 from each monomer (Figures 3E
and 3F). The side chains of residues Lys 216 and Glu223
from one monomer form ionic bonds with Glu223
 and
Lys216
 of another. The side chains of residues Val227,
Leu229, part of Lys216, and Glu223
 form one hydropho-
bic core, and the side chains of Val227
, Leu229
, part
of Lys216
, and Glu223 form another. The interaction of
residues Leu224 and Leu224
 further bolsters the flap-
flap interactions (Figures 3E and 3F).
The interactions of the third layer are among three
monomers, monomer 1, 1
, and 2
 (Figure 3G). The side
chain of residue Val219 from the flap region of monomer
1 interacts with the side chains of residues Ile150 and
Leu169 of monomer 2
 to form one hydrophobic core.
The side chain of residue Phe220 from the flap region
of monomer 1, side chains of residues Tyr192 and Ile250
from monomer 1
, and the side chain of residue Phe172
from monomer 2
 form another hydrophobic core. The
two hydrophobic cores, which bring three monomers
together, are separated by the main chain of the flap
from monomer 1 (Figures 3G and 3H). Additional hydro-
gen bonds formed by three monomers at this region
further intensify these tri-monomer-monomer interac-
tions. We believe that these interactions also greatly
improve the stability of the traditional trimer, which is
formed by monomers 1, 2, and 3 or monomers 1
, 2
,
and 3
 (Figure 3A).
The Existence of Virus-like Clusters in Solution
We employed two methods, gel filtration and electron
microscopy, to confirm that the virus-like assembly of
sTALL-1 exists in solution and is not the result of a
crystal-packing artifact. The assembly state of sTALL-1
was investigated on a Superose-6 gel-filtration column.
From the final elution profile, the sTALL-1 sample con-
tains assemblies with an estimated molecular weight
greater than 670,000 Da and smaller than 2,000,000 Da,
consistent with the calculated molecular weight of the
60-mer virus-like assembly of approximately 1,200,000
Da. To evaluate the stability of the assembly, different
salt concentrations were applied. Three salt concentra-
tions (10 mM NaCl, 500 mM NaCl, and 1 M NaCl in 50
mM Tris-HCl buffer at pH 8.0) led to the same sharp
elution profile, consistent with our structural information
that the trimer-trimer interactions involve not only elec-
trostatic contacts but also extensive hydrophobic con-
tacts. These results also can be repeated on the Super-
dex-200 gel-filtration column (Superdex-200 HR10/60,
Pharmacia), although sTALL-1 came out at a void vol-
ume (V0, 48 ml) (Figure 4A).
Our results are not consistent with two published re-
sults (Schneider et al., 1999; Kanakaraj et al., 2001), both
of which claimed that sTALL-1/BAFF existed only as
trimers. Comparing our experimental procedures with
theirs, we noticed that the analyses of sTALL-1/BAFF
were carried out at different pHs: pH 6.0 in the Kanakaraj
Figure 2. The Relative Position of an Asymmetry Unit in the Cluster study, pH 7.0 in the Schneider study, and pH 7.4 and
and Overall Structures of the Cluster at Different Orientations
(A) The ten monomers (yellow) in the asymmetric unit, which gener-
ate the left 50 monomers (colored gray) through crystallographic
symmetry (P6322) to form the virus-like cluster with total of 60 mo- local five-fold symmetry, and (C) looking down from the three-fold
nomers. symmetry. All monomers are colored according to chains as default
(B) The structure of virus-like cluster (T  1) looking down from the set in RIBBON (Carson, 1987).
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above in our studies. To evaluate the influence of pH with our observation of a hydrophobic core formed by
residues from three monomers at the momoner-mono-on the oligomeric state of sTALL-1, we ran gel filtrations
of sTALL-1 from bacteria on Superdex-200 at a series mer interaction interface. Although the flap regions of
one trimer do not involve in the formation of the trimerof pHs (Figure 4A). At pH 6.0, sTALL-1 exists exclusively
as trimers. The ratio of oligomers to trimers at pH 6.5 itself (Figure 1C), they do affect the stability of neigh-
boring trimers. These data are also consistent with thewas 1:2 and rose to 1:1 at pH 7.0, and the majority are
oligomers (30:1) at pH 7.2. At pH 7.4 we could detect observation that for some family members, trimers can
be transformed to monomers over a period of time inonly oligomeric sTALL-1 (Figure 4A). To rule out that
sTALL-1 from different sources may behave differently, solution (Cha et al., 1999; Corti et al., 1992).
From the structural results, we note that the flap regionwe analyzed purified sTALL-1 from the 293 cell line as
well as sTALL-1 produced by a mouse myeloma cell line is in the corresponding location for the binding of one
CRD of the cognate receptors of TNF and TRAIL. To(R&D Systems, Inc., Minneapolis). Both existed exclu-
sively as oligomers at pH 7.4 (data not shown). We be- investigate if the truncation of the flap region of sTALL-1
affects its receptor binding capacity and affinity, bindinglieve that two histidine residues (with pK2  6.0) in the
flap region may play crucial roles in the pH-dependent assays of native and truncated sTALL-1 to the cognate
receptor BCMA were carried out. Flow cytometry analy-association and dissociation property of sTALL-1 (Fig-
ures 3C and 3D). Interestingly, there are trimers as well sis results showed that the truncated sTALL-1 and the
wild sTALL-1 had similar binding capacity to cells thatas monomers of sTALL-1 at pH 7.0.
The 200-A˚-diameter virus-like assembly observed in overexpressed entire BCMA (Figure 4B). The binding affin-
ity of BCMA for the wild-type versus mutant sTALL-1the crystal structure is of sufficient size to be easily
detected by electron microscopy. This proved to be was further determined using BIACore surface plasmon
resonance. To obtain the true affinity of the receptorthe case. The negatively stained virus-like clusters are
clearly observed in electron micrographs after absorp- without the confounding effect of multivalent binding,
the polyvalent TALL-1 proteins were immobilized in thetion of the sample to a carbon electron microscope
(Figure 5A). The diameter and the shape of the particle instrument flow cells, and the soluble monomeric BCMA
was injected in the mobile phase. The KD of the interac-observed by electron microscopy is consistent with the
crystal structure (Figures 5B and 5C). tion was calculated by Scatchard analysis of the equilib-
rium data (Figure 4C). The receptor bound to the two
ligands with very similar affinity, indicating that the re-Possible Functional Units
moval of the TALL-1 flap did not alter its affinity for itsFrom the previous results discussed in the introduction,
receptor. An affinity of about 100 nM for this monomerthe trimer is believed to be the functional unit for the
interaction is consistent with reports of 0.1–1.0 nM ap-TNF ligand family members (Locksley et al., 2001; Fesik,
parent affinities for trivalent interactions of TNF family2000; Figure 1C). Due to the intensive interactions
members with immobilized or cell bound receptors. Itamong the sTALL-1 trimers in the crystal structure, we
is clear that the flap region is not involved in receptorpropose that the functional unit comprises more than a
binding.single trimer. Based on the crystal structure of sTALL-1,
To understand the functional role of the flap region,we can isolate several possible subclusters that may
transfection assays of both wild-type and truncatedact as the functional unit in vivo. The first is the dimer
sTALL-1 were performed. Wild-type sTALL-1 gave aof trimers (Figure 3A). The second is the tetramer of
dose-dependent activation of NF-kB in reporter genetrimers (Figure 6A). The third is the pentamer of trimers,
assays (Shu and Johnson, 2000). Truncated sTALL-1which is formed by encircling trimers (Figure 6B). Finally,
was defective in activating NF-B at a variety of BCMAbased on the gel filtration and electron microscopy re-
concentrations (Figure 4D). These data demonstratedsults, we suggest that the most likely functional unit is
that, despite the normal binding of the truncatedthe entire virus-like cluster (Figure 2).
sTALL-1 to the receptor, the flap region is essential for
the proper function of sTALL-1 in vivo.Deletion Analysis
To avoid possible artificial results brought in from theTo further confirm the exact region that leads to the
293 cell transfection assay system, B lymphocyte (fromformation of the virus-like cluster and the functional role
human peripheral blood of health donors) proliferationof the flap region, we constructed a mutated version of
stimulation by wild-type sTALL-1 and mutant sTALL-1sTALL-1 with eight residues replaced by two glycines
were carried out. Costimulation assays indicated that wild-at the flap region (residues 217–224). The truncated
type sTALL-1, but not mutant sTALL-1, significantly (p sTALL-1 (sTALL-1217–224) was overexpressed and
0.01) stimulate B lymphocyte proliferation (Figure 4E).purified as the native sTALL-1 (see Experimental Proce-
dures). Gel filtration of this sample on a Superdex-200
column yielded two peaks with molecular weight of Clusters under Physiological Condition
To assess whether the sTALL-1 cluster exists in vivo,around 60,000 Da and 20,000 Da (Figure 4A). These
peaks consistently appear in the elution profile at all medium from sTALL-1 overexpressing 293 cells was
collected and loaded onto a gel-filtration column (Super-three salt concentrations. These molecular weights cor-
respond to a monomer and a trimer of the truncated dex-200 HR 10/60, Pharmacia) eluting with PBS buffer
at pH 7.4. The eluted fractions were then subjected tosTALL-1. These data demonstrate that after truncation
of the flap region, the cluster-forming property of Western blot analysis. sTALL-1 exists both as clusters
and trimers, judging from the elution volumes (FiguresTALL-1 is abolished. Furthermore, disruption of the flap
region also affects trimer formation, which is consistent 4A), indicating that sTALL-1 clusters could exist under
Cell
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Figure 3. Detailed Trimer-Trimer Interactions
(A) Stereo view of the interactions between two sTALL-1 trimers. Trimer 1 consists of monomers 1 (light gray), 2 (gray), and 3 (dark). Trimer
2 contains monomers 1
, 2
, and 3
.
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physiological condition. To find out if there is an equi- 7). For example, residues Met208 and Ile212 on strand
librium between clusters and trimers, the two peaks D must be hydrophobic for the proper formation of the
corresponding to clusters and trimers were collected, hydrophobic core. A similar situation exists for residues
concentrated, and finally applied back to the same gel- Leu229 and Phe230 on strand E. All other family mem-
filtration column. For the cluster peak fraction, the same bers with unknown structures were aligned according
elution profile was obtained, a single sharp and symmet- to this pattern (Figure 7).
ric peak at the cluster position; there was no detectable From the alignment results, it is obvious that the loop
sTALL-1 at the trimer position. On the other hand, the region connecting  strands D and E is diverse. sTALL-1
trimer peak fraction generated two peaks corresponding has the longest sequence in this region. It is difficult to
to the cluster and trimer positions (Figure 4A). It is clear judge if any other member will form the flap region as
that sTALL-1 is predominantly in the cluster state rather in sTALL-1. Further structural, functional, and analysis
than a trimer in solution at pH 7.4. The process of cluster of solution properties for each individual family member
formation from trimers is irreversible. will be necessary. Given the fact that other family mem-
bers bind receptors with three or more CRDs, the possi-
bility of virus-like clusters as the functional unit may beReceptor Recognition
limited. This does not exclude the possibility of weaksTALL-1 binds with similar affinities to the receptors
trimer-trimer interaction for functional purpose. If theBCMA and TACI. BCMA contains one CRD while TACI
flap exists for functional purposes in other family mem-contains two CRDs. It is likely that only one CRD of
bers, it is possible that only CRD1 of their cognate recep-TACI, more specifically CRD1, is involved in interactions
tors takes part in the recognition. One interesting obser-with sTALL-1. If CRD2 of TACI bound to sTALL-1, CRD1
vation is that there is a complementary region in receptorswould clash with the flap region, based on homology
of TNF and TRAIL that interacts with this region in amodels generated from TNF complexed with its recep-
fashion similar to the trimer-trimer interactions of sTALL-1.tor and TRAIL with DR5 (Banner et al., 1993; Mongkolsa-
It is possible that this region may mediate intermolecularpaya et al., 1999; Hymowitz et al., 1999). There is a region
interactions in vivo, and the corresponding receptor maycorresponding to the elbow in TRAIL, which is partially
compete for binding to this region.ordered and is involved in interactions with its receptor
(Mongkolsapaya et al., 1999; Hymowitz et al., 1999). We
speculate that this elbow region in sTALL-1 and other
Possible Mechanismregions such as connection regions of strands CD, EF,
Current data indicate that TNF family ligands functionand GH make contacts with CRDs of BCMA and TACI.
as trimers binding to the cognate receptors. The recruit-As we pointed out earlier, the sTALL-1 trimer is shorter
ment of receptors leads to clustering of the cytoplasmicthan that of any other known TNF ligands along the
trimer forming three-fold axis. This is consistent with domains, which in turn stimulates the recruitment of
our proposal that only one receptor CRD makes contact adaptor proteins and other downstream partners. The
with sTALL-1. virus-like cluster of sTALL-1, which we have shown is
required for function, contradicts this paradigm. There
is one possible mechanism that may involve the activa-Flap for Other Family Members
tion of the downstream pathway. The virus-like cluster ofOur structural and functional analysis indicates that the
sTALL-1 could recruit numerous receptor trimers. ThissTALL-1 flap region mediates the cluster assembly for-
increase of local concentration of the receptors couldmation and is essential for the activation of NF-B. Does
facilitate signaling through the cellular membrane to thethis flap region exist in other family members? To ad-
cytoplasm of the cell. The clustering of numerous cyto-dress this question, we performed a structure-based
plasmic domains could lead to signal amplification bysequence alignment of all available 18 family members
recruiting downstream elements. This model resembles(Locksley et al., 2001). The four known TNF ligand struc-
the well-characterized SMAC (supermolecular activa-tures (Jones et al., 1989; Eck and Sprang, 1989; Eck et
tion cluster) complexes (Monks et al., 1998), in whichal., 1992; Karpusas et al., 1995; Cha et al., 1999) were
multiple copies of T cell receptors, peptide bound majorsuperimposed on sTALL-1 by the program DALI (Holm
histocompatibility complex molecules, other related ac-and Sander, 1993). To search possible flap regions in
cessory proteins, and their counterreceptors fromother members, the sequences that span  strands D
T cells and antigen-presenting cells gather together toand E from the five structures were aligned based on
form clusters that resemble neural synapses (Monks etthe structural superimpositions. The hydrophobic pat-
tern was obvious in this region after alignments (Figure al., 1998).
(B) The major interaction is involved in two monomers (monomers 1 and 1
). There are two layered interactions, termed layer 1 (L1) and layer 2 (L2).
(C) Residues and locations of layer 1.
(D) Stereo view of the interactions of layer 1.
(E) Residues and locations of layer 2.
(F) Stereo view of the interactions of layer 2.
(G) Residues and locations of the third layer interactions that involve three monomers, monomers 1 (yellow), 1
 (gray), and 2
 (dark).
(H) The stereo view of the two hydrophobic cores formed by residues from three monomers (residues from monomer 1 are red, residues from
monomer 1
 are blue, and residues from monomer 2
 are dark). If not specifically noted, all protein samples in above experiments were
prepared from E. coli overexpression system.
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Figure 4. Characterization of Wild-Type (sTALL-1) and Mutant (mTALL-1) sTALL-1 In Vitro and In Vivo
(A) Gel filtration at different pHs and Western blot results of sTALL-1 and mTALL-1 derived from bacteria and 293 cells.
(B) The binding capacity of sTALL-1 (solid line) and mTALL-1 (dotted line) derived from flow cytometry.
(C) The binding affinities of sTALL-1 and mTALL-1 to extracellular domain of BCMA derived from BIAcore.
(D) The transfection activities of sTALL-1 at 100 ng/ml (black), mutant sTALL-1 at 100 ng/ml (gray), and left untreated (open) under varied
transfection concentrations of BCMA.
(E) B lymphocyte proliferation results of sTALL-1 and mTALL-1 with anti-IgM of 2 g/ml, with sTALL-1 and mTALL-1 of 10 ng/ml. Markers
are Blue dextran (2000 kDa), Thyroglobulin (669 kDa), Ferritin (440 kDa), Albumin (67 kDa), Ovalbumin (45 kDa), and -Lactalbumin (14 kDa).
Application Potential serve as a therapeutic candidate for treating autoim-
mune diseases. The truncated version of sTALL-1 lacksAs demonstrated by multiple laboratories, administra-
tion of sTALL-1 can cause autoimmune disorders like the ability to form clusters and is defective in NF-B
activation function, but still binds to its cognate recep-lupus in mice (Gross et al., 2000, Mackay et al., 1999;
Khare et al., 2000). We reason that a nonfunctional muta- tor, making it a possible candidate for this purpose. One
concern is that the valence difference could make thetion of sTALL-1, which still has similar binding affinity
to its receptors competing with native sTALL-1, could mutant sTALL-1 less competitive.
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Figure 5. Overviews of sTALL-1 Clusters under Different Environments
(A) The electron microscopy view of sTALL-1 in solution after negative staining. The black bar is 50 nm long. Clusters of sTALL-1 are around
20 nm in diameter.
(B) Surface presentation of sTALL-1 viewing from a similar orientation as Figure 2B, and (C) from a similar orientation as Figure 2C. Figures
5B and 5C are generated by GRASP (Nicholls et al., 1991).
speed spin, the soluble fraction was loaded onto a Ni2-chelatingInterestingly, from sequence alignments, the trun-
affinity column, and His6-sTALL-1 was eluted with 100 mM imida-cated version of sTALL-1 is similar to TALL-2, the closely
zole. His6-sTALL-1 was loaded onto a MonoQ (Pharmacia) ion-related family member of TALL-1. Moreover, all residues
exchange column. After elution with a NaCl gradient, the protein
that take part in the trimer-trimer interactions are not was homogeneous as judged by Coomassie-stained SDS-polyacryl-
conserved between TALL-1 and TALL-2. It seems im- amide gels. The His6-tagged fusion protein was used for final crystal-
lization screen. sTALL-1 (15 mg/ml) was crystallized by vapor diffu-possible for TALL-2 to form the virus-like cluster. It is
sion against 5 mM -mercapotethanol, 50 mM Bicine (pH 9.0), 150suggested that TALL-2 may act as a decoy ligand in
mM NaCl, and 35%–38% dioxane. Heavy-atom derivatives werevivo, although there is a report suggesting that TALL-2
prepared by soaking crystals for 24 hr in 1 mM HgCl2 and for 48 hrfunctions similar to TALL-1 to stimulate B cell prolifera-
in 1 mM Mersayl, all dissolved in the crystallization solution. For
tion (Yu et al., 2000). The disability of TALL-2 to bind to cryocrystallography, crystals were soaked in 35% MPD with crystal-
BAFF-R indicates structural diversity between TALL-1 lization buffer for 30 min before flash-freezing.
The extracellular domain of BCMA (residues 1–51) for BIAcoreand TALL-2 (Schiemann et al., 2001). Further investiga-
experiments was overexpressed as GST-BCMA fusion protein ontion of the TALL-2 function will be essential to prove or
pGEX4T-2 vector in BL-21 strain. Cell preparation and protein purifi-rule out these speculations.
cation procedure are similar to that of sTALL-1. Briefly, harvestIn conclusion, the crystal structure of sTALL-1 reveals
cells were broken through a French press and low-speed spin. The
the virus-like structure of a member of the TNF ligand soluble fraction was loaded onto GST affinity beads. After intensive
family. Furthermore, this structural assembly may un- wash with binding buffer, thrombin was added for 24 hr incubation.
Supernatant that contained the extracellular domain of BCMA wasderlie a unique activation mechanism for TALL-1/BCMA,
loaded onto a MonoQ column and eluted with NaCl gradient. TheBAFF-R, and TACI signal transduction pathways. This
protein is above 99% pure after MonoQ.finding could provide new insights for the development
of new treatments for a variety of diseases such as
Structure Determination and Refinementtumors, autoimmune lupus, and others. Nevertheless,
Crystals of sTALL-1 diffracted to 3.5 A˚ and have high mosaicitythe actual regulatory mechanism for how sTALL-1’s
(above 1.0). Large crystal sizes did not improve the crystal diffrac-binding to its receptor couples signal transduction
tion ability and mosaicity. Altering crystallization conditions did not
through the membrane is still unclear. Structural infor- produce any better results. Finally, mercury treatments (sTALL-1
mation on complexes of sTALL-1 ligand with the entire sample was soaked in 0.1 mM HgCl2 for 10 hr) on the sTALL-1
protein before crystallization were employed. This sample producedreceptor will be instrumental to dissect the mechanism.
crystals at similar conditions as the native protein of sTALL-1. The
new crystals diffracted to 2.8 A˚ at an in-house X-ray generatorExperimental Procedures
and with reasonable mosaicity (0.5). The cell dimensions of these
crystals are 234  234  217 A˚ and these crystals are in spaceProtein Expression, Purification, and Crystallization
The cDNA fragment encoding amino acids 134–285 of human group P6322. The molecular weight of the His6-tagged sTALL-1 is
20 kDa. Assuming all monomers form trimers in solution and crys-TALL-1 was amplified from a TALL-1 full-length cDNA clone (Shu
et al., 1999; Shu and Johnson, 2000) by PCR using a plasmid tem- tal packing, it was impossible for us to define the exact solvent
contents of the sTALL-1 crystals (Matthews, 1968). All data sets areplate and primers containing restriction sites for pET14b (tagged
with His6) (Novergen). The final clones have been verified by restric- processed by DENZO and SCALEPACK (Otwinowski and Minor,
1997). Due to the low sequence homology among TNF ligand familytion digestion and DNA sequencing. The recombinant plasmid con-
taining the sTALL-1 gene was transformed to E. coli BL21(DE3)- members, we expected that it might be difficult to find molecular
replacement solutions. This turned out to be the case when we triedpLysS. Enhanced expression of His6-sTALL-1 was induced by
adding IPTG (isopropyl-1-thio-b-D-galactopyranoside) to a 8 l grow- all available molecular replacement programs. Based on our initial
Vm analysis, there are at least three trimers or nine monomers in aning culture (37C) at an OD650 of 0.7. After 4 hr of additional growth,
cells were harvested and resuspended in buffer (50 mM Tris-HCl, 1 asymmetry unit. We tried both monomer and trimer of TNF, TNF,
CD40L, and TRAIL as initial search models. All of these searchmM EDTA [pH 8.0], 300 mM NaCl, 5% glycerol, and 1 mM DTT).
After cell lysis through a continuous-flow French press and a low- models failed to generate a molecular replacement solution. Tradi-
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Figure 7. Structure-Based Sequence Alignments of TNF Ligand
Family Members at the Region Spanning  Strands D and E
Conserved hydrophobic residues are bold. Sequence source is from
Locksley et al., 2001.
noncrystallographic symmetry constrains. The output model was
then subjected to the “slow cooling” dynamic annealing refinement
and a group B factor refinement. The final refined R factor is 23.6%
and Rfree is 25.2%. It is a surprise to us that there are no mercury
atoms in the sTALL-1 structure, which is derived from the pre-HgCl2,
treated sample, although the behavior of the sTALL-1 sample was
completely changed after the HgCl2 treatments.
Electron Microscopy
A volume of 5 l of sTALL-1 suspension (5 mg/ml) was applied for
1 min onto carbon-coated grid previously glow discharged. After
removing the excess liquid with a filter paper, the grid was washed
with 2 drops of buffer and then negatively stained with saturated
uranyl acetate. Electron micrographs were recorded at a magnifica-
Figure 6. Possible Subclusters of sTALL-1 Trimer for Functional Units tion of 60,000 with a Philips CM12 transmission electron micros-
copy (Philips Electron Optics, Eindhoven, The Netherlands) op-(A) The arrangements of four trimers (trimers 1–4) of sTALL-1 in the
erating at 100 kV.virus-like cluster.
(B) Five trimers (trimers 1–5) of sTALL-1.
Protein Binding and Transfection Assays
Wild-type multimeric sTALLl-1 and mutant trimeric sTALLl-1 weretional heavy-atom screens were carried out. Two mercury deriva-
tives (Table 1) were found. Three data sets of sTALL-1 were input immobilized (11,000 and 3,000 RU, respectively) in separate flow
cells of a CM-5 BIAcore Biosenser chip using standard amine cou-to the program SOLVE (Terwilliger et al., 1987), and the output map
were subjected to solvent flattening in SOLOMON (CCP4, 1994). pling reagents. Various concentrations (10–1000 nM) of monomeric
BMCA were injected for 1 min at a flow rate of 20 l/min in aThe solvent-flattened map was used for model building in O (Jones
et al., 1991). The 3.0 A˚ MIR map of sTALL-1 has excellent quality. buffer of 100 mM NaCl, 20 mM Tris-HCl (pH 8.0), and 0.005% P20
detergent, and the binding kinetics were recorded. For baselineAll side chains of residues 142–285 were resolved. Tracing and
model building were performed with the help of a TNF model (Eck calculations, the same BMCA samples were injected in a control
flow cell with no protein immobilized. Receptor binding kineticset al., 1992). The ten mercury sites per asymmetric unit and their
symmetry-related sites lead to two ball-like arrangements in one were too rapid for accurate measurements of on rates and off rates,
but equilibrium binding values (Rmax) were used to calculate theunit cell (a  b  234 A˚, b  217 A˚,     90,   120), with
each ball containing 60 sites. This feature reminds us of a T  1 overall affinity of receptor binding by Scatchard analysis.
Luciferase reporter gene assays were carried out as describedvirus structure and also indicates that there are ten monomers in
the asymmetry unit instead of integrate numbers of trimers as we (Shu and Johnson, 2000). Briefly, 293 cells were transfected with
0.5 g of NF-B luciferase reporter plasmid and increased amountshad assumed in the calculation of solvent contents initially. The ten
monomers of the asymmetry unit were built independently. sTALL-1 of an expression plasmid for BCMA. At 14 hr after transfection, cells
were treated wild-type sTALL-1, mutant sTALL-1, or left untreatedmodel was first subjected to rigid body refinement and then conven-
tional positional minimization in CNS (Brunger et al., 1998) with for 7 hr, and luciferase reporter assays were performed.
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Flow Cytometry Analysis ardo, M.J. (2000). A domain in TNF receptors that mediates ligand-
independent receptor assembly and signaling. Science 288, 2351–BCMA-transfected 293 cells were incubated with control medium,
wild-type sTALL-1 in the control medium, and mutant sTALL-1 in 2354.
the control medium. Cell staining was performed by sequential incu- Corti, A., Fassina, G., Marcucci, F., Barbanti, E., and Cassani, G.
bation (each 40 min) with anti-His6 mAb and RPE-conjugated goat (1992). Oligomeric tumor necrosis factor slowly converts into inac-
anti-rabbit IgG in staining buffer. The fluorescence was measured tive forms at biological levels. Biochem. J. 284, 905–910.
by using a Becton Dickinson FACScan flow cytometer (Shu and
Eck, M.J., and Sprang, S.R. (1989). The structure of tumor necrosis
Johnson, 2000; Figure 4B).
factor-alpha at 2.6 A˚ resolution. Implications for receptor binding.
J. Biol. Chem. 264, 17595–17605.
B Cell Proliferation Assays
Eck, M.J., Ultsch, M., Rinderknecht, E., de Vos, A.M., and Sprang,B cell proliferation assays followed the procedure as described (Shu
S.R. (1992). The structure of human lymphotoxin (tumor necrosisand Johnson, 2000). Briefly, human peripheral B lymphocytes were
factor beta) at 1.9 A˚ resolution. J. Biol. Chem. 267, 2119–2122.purified from peripheral blood of health donors. Purified B lympho-
Fesik, S.W. (2000). Insights into programmed cell death throughcytes were seeded on 96-well dishes and treated with indicated
structural biology. Cell 103, 273–282.reagents for 40 hr. Cells were pulsed for an additional 10 hr with
[3 H]thymidine. Incorporation of [3 H]thymidine was measured by liq- Gross, J.A., Johnston, J., Mudri, S., Enselman, R., Dillon, S.R., Mad-
uid scintillation counting (Figure 4E). den, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al.
(2000). TACI and BCMA are receptors for a TNF homologue impli-
Gel Filtration and Western Blot cated in B cell autoimmune disease. Nature 404, 995–999.
Wild-type sTALL-1 and mutant sTALL-1 (each 1 mg) were loaded Gross, J.A., Dillon, S.R., Mudri, S., Johnston, J., Littau, A., Roque, R.,
onto the Superdex-200 HR 10/60 (Pharmacia), respectively. The Rixon, M., Schou, O., Foley, K.P., Haugen, H., et al. (2001). TACI-Ig
wild-type sTALL-1 came out at void volume (45–50 ml), and the neutralizes molecules critical for B cell development and autoim-
mutant trimers and momomers came out at elution volumes of 78 mune disease. Impaired B cell maturation in mice lacking BLyS.
ml and 87 ml, respectively (Figure 4A). Direct fresh medium (6 ml) Immunity 15, 289–302.
that grow 293 cells was loaded on to the Superdex-200 column.
Holm, L., and Sander, C. (1993). Protein structure comparison byAll fractions at different elution volume were concentrated for final
alignment of distance matrices. J. Mol. Biol. 233, 123–138.Western blot experiment, which were done by following the proce-
Hymowitz, S.G., Christinger, H.W., Fuh, G., Ultsch, M., O’Connell,dure as described (Shu et al., 1999); sTALL-1 were detected at
M., Kelley, R.F., Ashkenazi, A., and de Vos, A.M. (1999). Triggeringelution volume of 48 ml and 80 ml, respectively (Figure 4A).
cell death: the crystal structure of Apo2L/TRAIL in a complex with
death receptor 5. Mol. Cell 4, 563–571.Acknowledgments
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